J&J vaccination accused of causing life-threatening blood clots and rare bleeding diseases

Must read

US regulators have updated the fact sheet for Johnson & Johnson’s Covid-19 vaccine to include a warning about the possibility of a rare bleeding problem. In a letter to the business on Tuesday, the FDA stated that adverse-event records revealed an elevated risk of immune thrombocytopenia, or ITP, during the 42 days after immunization. According to the CDC, symptoms include bruising and unusual or excessive bleeding.

In a letter to the business on Tuesday, the FDA stated that adverse-event records revealed an elevated risk of immune thrombocytopenia, or ITP, during the 42 days after immunization. According to the CDC, symptoms include bruising and unusual or excessive bleeding. The fact sheet has been updated to add advice to immunization providers regarding providing the J&J vaccine to those who have pre-existing medical issues, such as those who have low platelets, a type of blood cell that helps stop bleeding.

The fact sheet has been updated to provide recommendations for vaccination providers when giving the J&J vaccine to people who have pre-existing medical conditions, such as low platelets, a kind of blood cell that helps stop bleeding. “People who have previously been diagnosed with ITP should discuss the risk of ITP and the potential need for platelet monitoring following vaccination with their healthcare provider,” J&J stated in a statement.

J&J’s vaccine has also been linked to thrombosis with thrombocytopenia syndrome, or TTS, a condition that causes rare but dangerous blood clots. Women aged 30 to 49 were the most vulnerable, according to the Centers for Disease Control and Prevention. So far, the single-dose vaccine has been administered to around 17 million Americans. For adults, the CDC recently recommended Moderna Inc. and Pfizer Inc. messenger RNA vaccinations over J&J’s injectable.

Continue Reading on Spot Latest

 

- Advertisement -spot_img

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -spot_img

Latest article